According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 5.09%, which ...

UNH is making significant investments in AI and digital tools to enhance consumer experiences and streamline healthcare ...

Elevance Health‘s stock rating was upgraded from “hold” to “buy” by Argus, with a price target of $450. Several other firms ...

UnitedHealth Group is bracing for scrutiny from the Trump administration over the way it and other Medicare Advantage insurers bill the government, along with other cost-related topics, an executive ...

U.S. health benefits company Elevance Health, Inc. ELV appears undervalued. It is currently trading at 12.25X forward 12-month earnings, below its five-year median of 13.44X and the industry average ...

Daneshvar Rohinton of iA Global Asset Management is expecting an economic realignment as many countries look at becoming more ...

Mehmet Oz, President Trump's nominee to become administrator of CMS, sidestepped a question at a Senate confirmation hearing Friday on whether he supports Medicaid being considered by Republican ...

Dr. Mehmet Oz, during its confirmation hearing in front of the Senate Finance Committee, said he would address Medicare Advantage upcoding, ...

Mehmet Oz, President Donald Trump’s nominee to lead Medicare and Medicaid, told senators he would focus on chronic disease ...

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Mehmet Oz, President Donald Trump’s nominee to lead the Centers for Medicare and Medicaid Services, may have “significantly” ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...